H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Cat. No.
GM-C40599
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C40599
Product H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Description H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) is a clonal stable HEK-293 cell line that constitutively expresses the human PDCD1(PD-1) gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_PDCD1(PD-1)
Gene ID/Uniprot ID Q15116
Host Cell HEK-293
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C40599
Product H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Description H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) is a clonal stable HEK-293 cell line that constitutively expresses the human PDCD1(PD-1) gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_PDCD1(PD-1)
Gene ID/Uniprot ID Q15116
Host Cell HEK-293
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) was determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) and H_PDCD1(PD-1) HEK-293 Cell Line (Cat. GM-C40031) were determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
Stability
The passage stability of the H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) was determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
Assay Performance
Response to Anti-PD1 hlgG1 Antibody. Serial dilutions of the Anti-PD1 hlgG1 Antibody (Cat. GM-87952AB) and 1E5 cells/well of the ADCC FcγRIIIa(158V) Jurkat Effector Cell Line (Cat. GM-C05619) were added to 1E4 cells/well of H_PDCD1(PD-1) CHO-K1 Cell Line (Low Expression) (Cat. GM-C42274) and H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599), respectly. Cells were incubated for 6 h. Firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). Data are shown by drug mass concentration. H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) lacks detectable ADCC activity.
Materials
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Genomeditech/GM-C05619
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Genomeditech/GM-C05619
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Sequence

  PDCD1(PD-1) Q15116MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL

  PDCD1(PD-1) Q15116MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL

Related products
PD-1:PD-L1(B7-H1):PDL2
Mouse_PDL1 KO CT26 Cell Line Mouse_PDL1 KO LLC1 Cell Line Mouse_PDL1 KO MC38 Cell Line
aAPC(OKT3) PDL1 CHO-K1 Cell Line H_PD-1 Reporter Jurkat Cell Line H_PD1 SHP1 Reporter Jurkat Cell line
H_PD1 SHP2 Reporter Jurkat Cell Line H_PDCD1LG2(PDL2) aAPC CHO-K1 Cell Line Mouse PDL1 aAPC CHO-K1 Cell Line
Mouse_PD-1 Reporter Jurkat Cell Line Canine_PD-1 CHO-K1 Cell Line Canine_PD-1 HEK-293 Cell Line
Cynomolgus_PD1 CHO-K1 Cell Line Cynomolgus_PD-L1 HEK-293 Cell Line H_CD274(PD-L1) CHO-K1 Cell Line
H_CD274(PD-L1) MC38 Cell Line H_PDCD1(PD-1) CHO-K1 Cell Line H_PDCD1(PD-1) HEK-293 Cell Line
H_PDCD1LG2(PDL2) CHO-K1 Cell Line H_PDL1 CT26(mouse PDL1 KO) Cell Line H_PD-L1 HEK-293 Cell Line
H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 MC38(mouse PDL1 KO) Cell Line
H_PD-L1 Raji Cell Line M_PDCD1(PD-1) CHO-K1 Cell Line Rhesus_PDCD1(PD-1) CHO-K1 Cell Line
Anti-Canine_PD1 mIgG2a Antibody Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody Anti-CTLA4×PD-1 hIgG1 Reference Antibody
Anti-H_CD274(PDL1) hIgG1 Antibody Anti-H_PDCD1(PD1) hIgG1 Antibody Anti-H_PDCD1LG2 mIgG1 Antibody
Anti-H_PDL1 hIgG1 Reference Antibody Anti-mouse PD1 RIgG2a Antibody Anti-mouse PD-L1 mIgG1 Antibody
Anti-Mouse_PD1 mIgG1 Antibody Anti-mouse_PD1 mIgG1 Antibody Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
Anti-PD1 hIgG1 Reference Antibody  Anti-PD1 hIgG1 Reference Antibody Anti-PD1 hIgG4 Antibody
Anti-PD1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody 
Anti-PD-1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody Anti-PD-1 hIgG4 Reference Antibody
Anti-PD1-IL2v Fusion hIgG1 Antibody Anti-PD1-IL2v Fusion hIgG1 Antibody Anti-PD-L1 hIgG1 Reference Antibody
Anti-PDL1 hIgG4 Reference Antibody Anti-PD-L2 hIgG1 Antibody Anti-VEGF×PD1 hIgG1 Reference Antibody 
Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (Pumibio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody 
Biotinylated Human PD1 Protein; His-Avi Tag Biotinylated Human PDL1 Protein; His-Avi Tag Canine PD1 Protein; hFc Tag
Cynomolgus PDL1 Protein; His Tag Human PD1 Protein; hFc Tag Human PD1 Protein; His Tag
Human PDL1 Protein; His Tag Human PDL1 Protein; mFc Tag Human PDL2 Protein; His Tag
Human PDL2 Protein; mFc Tag Mouse PDL1 Protein; His Tag  
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Cat. No.
GM-C40599
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C40599
Product H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Description H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) is a clonal stable HEK-293 cell line that constitutively expresses the human PDCD1(PD-1) gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_PDCD1(PD-1)
Gene ID/Uniprot ID Q15116
Host Cell HEK-293
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C40599
Product H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC)
Description H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) is a clonal stable HEK-293 cell line that constitutively expresses the human PDCD1(PD-1) gene, constructed using lentiviral technology.
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_PDCD1(PD-1)
Gene ID/Uniprot ID Q15116
Host Cell HEK-293
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) was determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) and H_PDCD1(PD-1) HEK-293 Cell Line (Cat. GM-C40031) were determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
Stability
The passage stability of the H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599) was determined by flow cytometry using Anti-PD1 hIgG1 Antibody (Cat. GM-87952AB).
Assay Performance
Response to Anti-PD1 hlgG1 Antibody. Serial dilutions of the Anti-PD1 hlgG1 Antibody (Cat. GM-87952AB) and 1E5 cells/well of the ADCC FcγRIIIa(158V) Jurkat Effector Cell Line (Cat. GM-C05619) were added to 1E4 cells/well of H_PDCD1(PD-1) CHO-K1 Cell Line (Low Expression) (Cat. GM-C42274) and H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) (Cat. GM-C40599), respectly. Cells were incubated for 6 h. Firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). Data are shown by drug mass concentration. H_PDCD1(PD-1) HEK-293 Cell Line (Low Expression NOADCC) lacks detectable ADCC activity.
Materials
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Genomeditech/GM-C05619
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Genomeditech/GM-C05619
Anti-PD1 hIgG1 Antibody Genomeditech/GM-87952AB
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

 

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

 

 

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

 

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Sequence

  PDCD1(PD-1) Q15116MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL

  PDCD1(PD-1) Q15116MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL

Related products
PD-1:PD-L1(B7-H1):PDL2
Mouse_PDL1 KO CT26 Cell Line Mouse_PDL1 KO LLC1 Cell Line Mouse_PDL1 KO MC38 Cell Line
aAPC(OKT3) PDL1 CHO-K1 Cell Line H_PD-1 Reporter Jurkat Cell Line H_PD1 SHP1 Reporter Jurkat Cell line
H_PD1 SHP2 Reporter Jurkat Cell Line H_PDCD1LG2(PDL2) aAPC CHO-K1 Cell Line Mouse PDL1 aAPC CHO-K1 Cell Line
Mouse_PD-1 Reporter Jurkat Cell Line Canine_PD-1 CHO-K1 Cell Line Canine_PD-1 HEK-293 Cell Line
Cynomolgus_PD1 CHO-K1 Cell Line Cynomolgus_PD-L1 HEK-293 Cell Line H_CD274(PD-L1) CHO-K1 Cell Line
H_CD274(PD-L1) MC38 Cell Line H_PDCD1(PD-1) CHO-K1 Cell Line H_PDCD1(PD-1) HEK-293 Cell Line
H_PDCD1LG2(PDL2) CHO-K1 Cell Line H_PDL1 CT26(mouse PDL1 KO) Cell Line H_PD-L1 HEK-293 Cell Line
H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 LLC1(mouse_PDL1 KO) Cell Line H_PDL1 MC38(mouse PDL1 KO) Cell Line
H_PD-L1 Raji Cell Line M_PDCD1(PD-1) CHO-K1 Cell Line Rhesus_PDCD1(PD-1) CHO-K1 Cell Line
Anti-Canine_PD1 mIgG2a Antibody Anti-CTLA-4/PD-1 hIgG1 Bispecific Antibody Anti-CTLA4×PD-1 hIgG1 Reference Antibody
Anti-H_CD274(PDL1) hIgG1 Antibody Anti-H_PDCD1(PD1) hIgG1 Antibody Anti-H_PDCD1LG2 mIgG1 Antibody
Anti-H_PDL1 hIgG1 Reference Antibody Anti-mouse PD1 RIgG2a Antibody Anti-mouse PD-L1 mIgG1 Antibody
Anti-Mouse_PD1 mIgG1 Antibody Anti-mouse_PD1 mIgG1 Antibody Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
Anti-PD1 hIgG1 Reference Antibody  Anti-PD1 hIgG1 Reference Antibody Anti-PD1 hIgG4 Antibody
Anti-PD1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody 
Anti-PD-1 hIgG4 Reference Antibody  Anti-PD1 hIgG4 Reference Antibody Anti-PD-1 hIgG4 Reference Antibody
Anti-PD1-IL2v Fusion hIgG1 Antibody Anti-PD1-IL2v Fusion hIgG1 Antibody Anti-PD-L1 hIgG1 Reference Antibody
Anti-PDL1 hIgG4 Reference Antibody Anti-PD-L2 hIgG1 Antibody Anti-VEGF×PD1 hIgG1 Reference Antibody 
Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody (Pumibio) Anti-VEGF×PD-L1 hIgG1 Bispecific Antibody 
Biotinylated Human PD1 Protein; His-Avi Tag Biotinylated Human PDL1 Protein; His-Avi Tag Canine PD1 Protein; hFc Tag
Cynomolgus PDL1 Protein; His Tag Human PD1 Protein; hFc Tag Human PD1 Protein; His Tag
Human PDL1 Protein; His Tag Human PDL1 Protein; mFc Tag Human PDL2 Protein; His Tag
Human PDL2 Protein; mFc Tag Mouse PDL1 Protein; His Tag  
Message consultation
reset
submit
Message
Message consultation
reset
submit